Company Filing History:
2 out of 3 
2 out of 3 
2 out of 6 Years Active: 2017-2022
Title: Therese Koal: Innovator in Biomarkers and Asphyxia Diagnosis
Introduction
Therese Koal is a prominent inventor based in Innsbruck, Austria. She has made significant contributions to the fields of cancer diagnostics and asphyxia treatment. With a total of 6 patents, her work focuses on developing innovative methods for assessing health conditions through metabolic biomarkers.
Latest Patents
One of her latest patents is centered around biomarkers for assessing breast cancer. This invention relates to a metabolic biomarker set that is used for screening and diagnosing breast cancer in mammalian subjects. The biomarker set includes specific amino acids and lipids, which are crucial for predicting therapeutic responses to neoadjuvant chemotherapy. Additionally, she has developed a method for assessing breast cancer that involves obtaining a biological sample, preferably blood, and measuring the amounts and ratios of metabolites present. This method enhances the reliability of breast cancer assessments.
Another significant patent involves a method for diagnosing and treating asphyxia. This invention provides a way to diagnose asphyxia and related disorders in vitro. It includes methods for estimating the duration of hypoxia in patients and monitoring various oxygen conditions. The method quantitatively detects specific endogenous compounds in biological samples, which are essential for understanding and managing asphyxia.
Career Highlights
Throughout her career, Therese Koal has worked with notable companies such as Metabolomycs, Inc. and Infandx AG. Her experience in these organizations has contributed to her expertise in metabolic research and diagnostics.
Collaborations
Therese has collaborated with professionals like Ismael Dale Cotrim Guerreiro Da Silva and Andre Lopes Carvalho. These partnerships have furthered her research and innovation in the medical field.
Conclusion
Therese Koal is a trailblazer in the development of diagnostic methods for breast cancer and asphyxia. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.